Palantir Stock vs. Nvidia Stock: Billionaires Are Buying One and Selling the Other

So far in 2024, the S&P 500 index has gained an impressive 26% while the tech-heavy Nasdaq Composite has soared roughly 28%. Without a doubt, one of the biggest tailwinds fueling these market returns is artificial intelligence (AI). Among AI’s hottest stocks through 2024 are …

Read more

Weekly Upgrades and Downgrades

I decided to revise my Stock Grader recommendations for 85 big blue chips. Source: iQoncept/Shutterstock.com During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close …

Read more

Wall Street Bulls Look Optimistic About Delta (DAL): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock’s price, but are they really important? Let’s take a look at what these Wall …

Read more

Top 3 Energy Stocks That Could Blast Off In December

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to …

Read more

Kirby McInerney LLP Reminds Humacyte (HUMA) Investors of Class Action Filing and Encourages Investors to Contact the Firm

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the North Carolina Middle District on behalf of those who acquired Humacyte, Inc. (“Humacyte” or the “Company”) HUMA securities during the period …

Read more

Prediction: This Artificial Intelligence (AI) Chip Stock Is Going to Skyrocket After Dec. 3

The market for artificial intelligence (AI) chips has been dominated by Nvidia, which explains why the semiconductor giant recently delivered another stellar set of results for the third quarter of fiscal 2025 (which ended on Oct. 27). The chipmaker’s revenue shot up a whopping 94% …

Read more

1 Stock to Buy, 1 Stock to Sell This Week: Robinhood, Dollar General

• U.S. jobs report, Powell speech will be in focus this week.• Robinhood is a buy as it holds its first ever Investor Day event.• Dollar General is a sell with shrinking profit growth, soft guidance expected.• Looking for more actionable trade ideas? Subscribe here …

Read more

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the …

Read more

Top 3 Defensive Stocks You'll Regret Missing In November

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared …

Read more

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Nov. 29, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humacyte, Inc. (“Humacyte” or “the Company”) HUMA for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 …

Read more